Hepatoma

MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.

A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors

The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/CT and Enhanced MRI in Hepatic Malignancies

Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery

Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma

Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery

Combination of Regorafenib and Nivolumab in Unresectable Hepatocellular Carcinoma

Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option

TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma

Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma

A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®

A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma

Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies

SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma

HepATocellular Cancer Hcv Therapy Study

IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Sorafenib and TRC105 in Hepatocellular Cancer

Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma

Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma